Wild-type p53 gene increases MDR1 gene expression but decreases drug resistance in an MDR cell line KBV200

被引:23
|
作者
Li, ZH
Zhu, YJ
Lit, XT
机构
[1] CHINESE ACAD MED SCI, INST CANC, DEPT PHARMACOL, BEIJING 100021, PEOPLES R CHINA
[2] BEIJING UNION MED COLL, BEIJING 100021, PEOPLES R CHINA
[3] CHINESE ACAD MED SCI, INST CANC, DEPT BIOCHEM, BEIJING 100021, PEOPLES R CHINA
基金
中国国家自然科学基金;
关键词
p53; gene; MDR1; drug resistance; anticancer drug; apoptosis;
D O I
10.1016/S0304-3835(97)00267-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inactivation of p53 gene and overexpression of MDR1 gene are both associated with drug resistance, Previous studies have suggested that p53 gene can modulate the expression activity of MDR1 gene promoter in a promoter-CAT system. In the present study, wild-type p53 gene cDNA was introduced into a multidrug-resistant cell line, KBV200, in which endogenous p53 gene is aberrant. In wt-p53 transfected cells, the expression of MDR1 gene was significantly increased, accumulation of adriamycin (ADM) was decreased, and the sensitivity to vincristine (VCR), ADM and 5-fluorouracil (5-FU) was increased compared with the parent KBV200 cells, After treatment with ADM and VCR, the p53-transfectants were more susceptible to apoptosis. The results suggest that the increase in drug sensitivity of the cells may be, at least in part, due to p53-dependent apoptosis induced by anticancer agents. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:177 / 184
页数:8
相关论文
共 50 条
  • [41] ΔNp73α regulates MDR1 expression by inhibiting p53 function
    A Vilgelm
    J X Wei
    M B Piazuelo
    M K Washington
    V Prassolov
    W El-Rifai
    A Zaika
    Oncogene, 2008, 27 : 2170 - 2176
  • [42] THE CLINICAL SIGNIFICANCE OF MULTIDRUG RESISTANCE GENE(mdr1) EXPRESSION IN ACUTE LEUKEMIA
    董作仁
    罗建民
    徐文新
    王福旭
    郭晓楠
    张学军
    姚尔固
    徐世荣
    任金海
    丛斌
    Chinese Journal of Cancer Research, 1998, (01) : 61 - 64
  • [43] Inducible expression of a selective repressor of the MDR1 multidrug resistance gene.
    Xu, D
    Bartsevich, VV
    Fisher, M
    Ye, D
    Juliano, RL
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3741S - 3741S
  • [44] MDR1 GENE-EXPRESSION AND TREATMENT OUTCOME IN SMALL-CELL LUNG-CANCER - MDR1 GENE-EXPRESSION AS AN INDEPENDENT PROGNOSTIC FACTOR
    TABATA, M
    OHNOSHI, T
    UEOKA, H
    KIURA, K
    KIMURA, I
    ACTA MEDICA OKAYAMA, 1993, 47 (04) : 243 - 248
  • [45] MULTIDRUG RESISTANCE GENE (MDR1) EXPRESSION IN HUMAN BRAIN-TUMORS
    NABORS, MW
    GRIFFIN, CA
    ZEHNBAUER, BA
    HRUBAN, RH
    PHILLIPS, PC
    GROSSMAN, SA
    BREM, H
    COLVIN, OM
    JOURNAL OF NEUROSURGERY, 1991, 75 (06) : 941 - 946
  • [46] Mithramycin represses MDR1 gene expression in vitro, modulating multidrug resistance
    Tagashira, M
    Kitagawa, T
    Isonishi, S
    Okamoto, A
    Ochiai, K
    Ohtake, Y
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2000, 23 (08) : 926 - 929
  • [47] ΔNp73α regulates MDR1 expression by inhibiting p53 function
    Vilgelm, A.
    Wei, J. X.
    Piazuelo, M. B.
    Washington, M. K.
    Prassolov, V.
    El-Rifai, W.
    Zaika, A.
    ONCOGENE, 2008, 27 (15) : 2170 - 2176
  • [48] MULTIDRUG-RESISTANCE GENE (MDR1) EXPRESSION IN HUMAN TUMOR XENOGRAFTS
    ABE, Y
    NAKAMURA, M
    OHNISHI, Y
    INABA, M
    UEYAMA, Y
    TAMAOKA, N
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 5 (06) : 1285 - 1292
  • [49] De novo deletions of p53 gene and wild-type p53 correlate with acquired cisplatin-resistance in human osteosarcoma OST cell line
    Asada, N
    Tsuchiya, H
    Tomita, K
    ANTICANCER RESEARCH, 1999, 19 (6B) : 5131 - 5137
  • [50] Clinical Study of Multi-drug Resistance Gene(MDR1) Expression in Primary Ovarian Cancer
    王世宣
    蔡桂茹
    Journal of Tongji Medical University, 1998, (01) : 58 - 60